November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
November 12-13, 2024
Novartis BioMedical Research
Cambridge, MA, USA
Harnessing the Power of Machine Learning to Rapidly Transform LC-MS Spectra into the Identity and Absolute Concentration of Detected Metabolites
Mimoun Cadosch Delmar Akerman, Matterworks
Molecular Generative Neural Networks: Navigating Latent Vector Space to Create New Tools for Analysis and Prediction
Alex Clark, Ph.D., Collaborative Drug Discovery
Real Time LC-Automated Analysis and Assessment of System Suitability
Nicole Ferreira, M.S., Merck
Rapid AI generation of Optimised Compound Designs Guided by User Interactions
Tamsin Mansley, Ph.D., M.R.SC., C.Chem., C.Sci. (Optibrium Inc.)
ML Algorithm for Detecting Activated T Cells: An Automated Multi-Cycle Tracking Workflow
David Nizovsky, 100XBIO
Learning Microbial Growth Dynamics
Vasu Rao, University of Michigan
AI Driven Automation of Model Selection and Data Quality Control in SPR Production Screens
Daniel Siegismund, Genedata AG
Generative AI Automation and Enhanced Untargeted Drug Metabolite Analysis Using High-Resolution Mass Spectrometry (HRMS): A Case Study in Lipid Identification
Lalin Theverapperuma, Ph.D., Expert Intelligence
Representation Learning of Cell Painting Images in Combination with Biological Knowledge Graph
Zhiyong Xie, Xellar Biosystems